Based on the above findings, we hypothesized that ICA could ameliorate AD-induced cognitive impairment by regulating synaptic plasticity deficits through targeting the BDNF/TrkB/Akt pathway. This evidence concerns the gene NTRK2 and Alzheimer disease.